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Fairness in Olympic sports: How can we control the increasing complexity
of doping use in high performance sports? ☆
With the Rio Olympics just a few months past, we remember
the excitement, the incredible performances, and the controver-
sies.As happens so often, the Olympic Games focus attention not
only on athletic achievements but also on how athletes may reach
ever-increasing levels of performance. Doping, medical doping
exemptions, and the ban of the Russian team for state-sponsored
organized doping of its athletes dominated the discussions.
After the Rio Olympics, it was revealed that many prominent
athletes had health-related drug exemptions and thus were allowed
to use medication containing substances banned by the World
Anti-DopingAgency (WADA).Particularly, exemptions for asthma
medication and attention deficit hyperactivity disorder came under
scrutiny.Thenumber of exemptions became suspiciouswhen itwas
revealed that in certain sports (e.g., cycling and swimming), the
percentageof athletes suffering fromasthma ismuchgreater than in
the average population. Asthma medications, such as salbutamol
and terbutaline, are said to be not performance enhancing, but they
will increase performance in asthmatic athletes by up to 10%.1
However, it is impossible to know what the normal performance
level of an asthma sufferer would be were she or he free of asthma.
This argument is reminiscent of the discussions surrounding Oscar
Pistorius, the double-amputee “blade runner” who participated in
the LondonOlympics, and scientists’ disagreements aboutwhether
Mr. Pistorius had an unfair advantage running with his specialized
lower limb prostheses. Of course, we will never know, because
nobody can determine with certainty how fast Mr. Pistorius could
have run the 400 sprint had he had his “normal” legs. One might
argue thatwhen a drug contains banned substances, there should be
no medical exemptions.Asthma sufferers should be allowed to use
banned substances but shouldbe categorized asParalympic athletes
and compete against each other in a separate competition. In swim-
ming and cycling, approximately 40% of all Olympic athletes
would fall into this category, making winning in the asthma cat-
egory as competitive as the regularOlympic swimming and cycling
competitions.
Another drug that has received intense scrutiny and press is
meldonium, which can be purchased under the trade name
Mildronate.Meldoniumwasdeveloped in the 1970s at theLatvian
Institute of Organic Synthesis in the former Soviet Union. It is
primarily used as a treatment against coronary artery diseases and
has seen widespread use among Eastern European athletes.
WADA put meldonium on the list of banned substances on
January 1, 2016, and subsequently several high-profile athletes
were caught using the substance. Prominently, in early March of
2016, the international tennis superstar Maria Sharapova
announced that she had failed a drug test at the Australian Open
Tennis Tournament. Meldonium had been found in her system,
and she admitted of having used meldonium for the past 10 years
for a variety of health problems. She argued that shewas not aware
that meldonium had been put on the banned substance list. Nev-
ertheless, she was suspended by the International Tennis Federa-
tion for a 2-year period (a suspension that has been appealed).
In the Journal of Sport and Health Science, Lippi and
Mattiuzzi2 give a detailed account of the health benefits of
meldonium and its possible benefits on athletic performance.
They argue that meldonium has no proven effect on perfor-
mance in elite athletes. However, meldonium’s mechanism of
action suggests that it might enhance endurance and might
allow for faster recovery from intense workouts.
The world of professional and Olympic sports has become big
business, and today’s superstar athletes have contracts worth mil-
lions of dollars. The prestige associated with an Olympic gold
medal, and the possibilities for converting success in sport into a
lucrative career,make it increasingly difficult to keep sports clean. I
believe that the issue of medical exemptions and the punishment of
athletes for failed drug testing need to be re-evaluated based on
strong philosophical and ethical grounding.The current system is a
patchworkwithgood intentions, but it is not fair andnotworkable in
the long term. If wewant to preserve “clean” competitions,WADA
needs to rethink the current system and policies from their very
foundations.
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